Kiran Mazumdar Shaw

Apr 27, 2016 at 11:59 | Source: CNBC-TV18
Biocon R&D team is working on the second phase of the development of oral insulin, and Kiran Mazumdar-Shaw, Chairman & MD, Biocon, hopes that it becomes an approved product in the next 2-3 years.
Mar 28, 2016 at 16:04 | Source: CNBC-TV18
Getting approval to sell the biosimilar drug Glargine in Japan will open doors for the company, feels Kiran Mazumdar Shaw, Chairperson and Managing Director of Biocon.
Mar 28, 2016 at 16:02 | Source: PTI
The Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the sale of Glargine, a significant achievement for Biocon and its commercial partner, Fujifilm Pharma, the biotech major said in a filing to BSE.
Mar 17, 2016 at 10:00 | Source: CNBC-TV18
Highlighting that the insulin market currently has just a handful of players and provides huge scope for growth, Kiran Mazumdar Shaw, CMD of Biocon says, the company will be filing its first insulin analogue dossier in FY17.
Feb 29, 2016 at 21:54 | Source: CNBC-TV18
In a panel discussion on CNBC-TV18, Kiran Mazumdar Shaw, CMD of Biocon said that the Finance Minister has made right investments in farming and drafted a reasonable Budget focusing on rural prosperity.
Feb 29, 2016 at 07:38 | Source: PTI
"I think it will, because it's too confused right now. The whole sector is being sort of under the purview of multi- ministerial control. So, I think that is causing a lot of chaos", the chief of Biocon, the country's biggest biotech company told PTI.
Feb 24, 2016 at 17:22 | Source: PTI
"According to me, right now, the government needs to only focus on ease of doing business and it should also focus on consistent policies, where there is no ambiguity and flip-flopping," Biocon chief Kiran Mazumdar-Shaw told PTI.
Feb 15, 2016 at 11:24 | Source: CNBC-TV18
Kiran Mazumdar-Shaw, Chairman of the company, expects the company to soon win approval in the US as well.
Feb 09, 2016 at 18:22 | Source: PTI
She said to dominate in the field such as biotechnology and information technology what is paramount is human capital, which will actually shape India's science and technology prowess in the world.
Feb 08, 2016 at 07:54 | Source: PTI
Recently, the Central Board of Excise and Customs (CBEC) had issued a notification withdrawing exemption of levy of basic customs duty on as many as 74 drugs.
Messages on Kiran Mazumdar Shaw »

stocktin

Platinum Member

64 Followers

Biocon  

which involves big bucks like the 2g,3g, coal etc.In the similar context industrialists like KMS are flower pots they r the face of Indian industry after all you cant showcase an ex custom house clearing agent like Gautam Adani to the world as the face of Indian Industry for that you need Kiran Mazumdar

6.31 PM Jun 9th 2014

Web Messenger

Platinum Member

343534 Followers

News Now  

Source:VC Circle - The company expects its small molecule API and ANDA business to be lead revenue generator followed by research services, biosimilars and branded formulations. Biocon Ltd is India's largest biotechnology company founded by Kiran Mazumdar-Shaw in ...

2.34 PM May 7th 2014

sanecounsel

Platinum Member

137 Followers

Biocon  

BANGALORE: Kiran Mazumdar-Shaw on Friday for the very first time used the words `succession planning`, after having built Biocon into a Rs 3,000-crore global biopharmaceutical enterprise and making it the poster child of India`s biotech prowess in a span of over three decades. The board of Biocon

11.32 AM Apr 27th 2014

stocktin

Platinum Member

64 Followers

Biocon  

ramanujam11 : Great post & the comparision with Apple .however , I am a little queasy about your first point regarding the ipo ,statin company & the hype.Who benefited from the hype created at the time of ipo?? And if this is true then everything that Biocon and Kiran Mazumdar Shaw stand for can

11.29 AM Mar 15th 2014

Web Messenger

Platinum Member

343534 Followers

News Now  

Source:The Hindu BusinessLine - Indian Institute of Management-Bangalore (IIM-B) has appointed Kiran Mazumdar-Shaw as the Chairperson of its board of governors. At the meeting of the board of governors on February 11, the Chairperson, Mukesh D. Ambani, expressed his decision to step down, IIM

4.35 PM Feb 19th 2014

srikanth031
086

Gold Member

183 Followers

Biocon  

Kiran Mazumdar-Shaw, chairman and managing director of Indian biopharmaceutical company Biocon Ltd., will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation’s 13th annual Heritage Day celebration May 15. CHF president and CEO Carsten Reinhardt said in a statement that Mazumdar

2.16 PM Jan 31st 2014

Web Messenger

Platinum Member

343534 Followers

Biocon  

Source:Economic Times - MUMBAI: Biocon has justified the Rs 19,500-57,500 pricing for its new breast cancer drug Canmab , with the company`s chairman and managing director Kiran Mazumdar-Shaw saying that the first biosimilar version of Swiss drug maker Roche`s offering has expanded the market.

12.04 PM Jan 25th 2014

Firstpost

Platinum Member

1132 Followers

Economy  

Source:FirstPost - Even though several corporate India executives have recently joined the Aam Aadmi Party while others like Bicon`s Kiran Mazumdar shaw have praised the party for itsanti-corruption stand and, the party` s populist measures are worrying investors on Dalal Street.At the heart

1.15 PM Jan 6th 2014

Web Messenger

Platinum Member

343534 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

7.08 PM Jan 2nd 2014

Web Messenger

Platinum Member

343534 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

1.04 PM Jan 2nd 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.